Lucintel's latest study found that, The future of the global interventional radiology product market looks promising with opportunities in the cardiology, urology & nephrology, oncology, gastroenterology, neurology, and orthopedics markets. The global interventional radiology product market is expected to reach an estimated $16.5 billion by 2030 with a CAGR of 6.7% from 2024 to 2030. The major drivers for this market are advantages of minimally invasive procedures over traditional open surgeries encompass enhanced safety, reduced scarring, and quicker recovery, increasing incidence of chronic illnesses and an aging population, and growing emphasis on the creation of smart/digital inhalers, soaring healthcare costs, and growing need for painless medication delivery.
In this market, catheter, stents, inferior vena cava filters, hemodynamic flow alteration devices, angioplasty balloons, thrombectomy systems, embolization devices, biopsy needles, and accessories are the major segments of interventional radiology product market by type.
Lucintel forecasts that stents will remain the largest segment over the forecast period due to escalating prevalence of cardiac ailments and cancer, coupled with the global surge in angioplasty procedures.
Browse in depth TOC of the Interventional Radiology Product Market
100 - Figures
150-Pages
Interventional Radiology Product Market is marked by presence of several big and small players. Abbott, Medtronic, Boston Scientific, Becton Dickinson and Company, and Terumo Medical are the major suppliers in the interventional radiology product market.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link [email protected]